» Articles » PMID: 23296953

Intestinal Mucosal Permeability of Children with Cefaclor-associated Serum Sickness-like Reactions

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2013 Jan 9
PMID 23296953
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Although the serum sickness-like reaction (SSLR) in children after the administration of cefaclor has long been recognized, the exact mechanism of cefaclor-associated SSLR remains unclear. This study aims to investigate the association between intestinal mucosal permeability and cefaclor-associated SSLR in children. A total of 82 pediatric patients with upper respiratory tract infection following the cefaclor therapy was divided into cefaclor-associated SSLR positive group and negative group based on the presence or absence of SSLR after taking cefaclor, and 30 healthy volunteers served as control group. Urinary lactulose/mannitol (L/M) ratios and serum diamine oxidase (DAO) levels were determined in all cases on days 7, 9, 11, 13, and 15 after oral administration of cefaclor. The children in the control group were given the same measurements after enrollment in this study. From days 7 to 13, the urinary L/M ratio of children with cefaclor SSLR gradually increased and reached to the highest level of 0.38 ± 0.14 on day 13. Compared with the cefaclor-associated SSLR negative group and control group, urinary L/M ratios increased significantly in the cefaclor SSLR positive group on days 7, 9, 11, 13, and 15 after taking cefaclor, and serum levels of DAO following the treatment of cefaclor increased significantly in children with cefaclor SSLR on days 9, 11, 13, and 15. No significant difference in urinary L/M ratios and serum levels of DAO between SSLR negative group and control group through the entire experiment was observed. In conclusion, administration of cefaclor may induce SSLR in children by increasing the intestinal mucosal permeability and/or affecting the integrity of the intestinal mucosa. Determinations of urinary L/M ratios and serum DAO levels may be helpful for observing or predicting the occurrence of SSLR after administration of cefaclor, which will encourage physicians to proceed with extreme caution when prescribing cefaclor for pediatric patients.

Citing Articles

Gut microbiota and host cytochrome P450 characteristics in the pseudo germ-free model: co-contributors to a diverse metabolic landscape.

Wang S, Wen Q, Qin Y, Xia Q, Shen C, Song S Gut Pathog. 2023; 15(1):15.

PMID: 36945019 PMC: 10029254. DOI: 10.1186/s13099-023-00540-5.


Serum sickness reaction to obinutuzumab in a patient with chronic lymphocytic leukaemia.

Elmanaseer O, Avelino A, Azem A, Raval M BMJ Case Rep. 2021; 14(12).

PMID: 34937753 PMC: 8704971. DOI: 10.1136/bcr-2021-245557.


Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice.

Peter J, Lehloenya R, Dlamini S, Risma K, White K, Konvinse K J Allergy Clin Immunol Pract. 2017; 5(3):547-563.

PMID: 28483310 PMC: 5424615. DOI: 10.1016/j.jaip.2017.01.025.


Mode of renal replacement therapy determines endotoxemia and neutrophil dysfunction in chronic kidney disease.

Lemesch S, Ribitsch W, Schilcher G, Spindelbock W, Hafner-Giessauf H, Marsche G Sci Rep. 2016; 6:34534.

PMID: 27698480 PMC: 5048306. DOI: 10.1038/srep34534.


Acute gastrointestinal injury in the intensive care unit: a retrospective study.

Chen H, Zhang H, Li W, Wu S, Wang W Ther Clin Risk Manag. 2015; 11:1523-9.

PMID: 26491339 PMC: 4599567. DOI: 10.2147/TCRM.S92829.

References
1.
Linskens R, Huijsdens X, Savelkoul P, Vandenbroucke-Grauls C, Meuwissen S . The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl. 2002; (234):29-40. DOI: 10.1080/003655201753265082. View

2.
Eccles M, Grimshaw J, Johnston M, Steen N, Pitts N, Thomas R . Applying psychological theories to evidence-based clinical practice: identifying factors predictive of managing upper respiratory tract infections without antibiotics. Implement Sci. 2007; 2:26. PMC: 2042498. DOI: 10.1186/1748-5908-2-26. View

3.
Jackson P, Lessof M, Baker R, Ferrett J, Macdonald D . Intestinal permeability in patients with eczema and food allergy. Lancet. 1981; 1(8233):1285-6. DOI: 10.1016/s0140-6736(81)92459-4. View

4.
Benjamin J, Makharia G, Ahuja V, Anand Rajan K, Kalaivani M, Gupta S . Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial. Dig Dis Sci. 2011; 57(4):1000-12. DOI: 10.1007/s10620-011-1947-9. View

5.
Menzies I, Laker M, Pounder R, Bull J, Heyer S, Wheeler P . Abnormal intestinal permeability to sugars in villous atrophy. Lancet. 1979; 2(8152):1107-9. DOI: 10.1016/s0140-6736(79)92507-8. View